Ya. G. Voronko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ya. G. Voronko has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Nikolay N. Landyshev
ФГАОУ ВО «Российский университет дружбы народов», Медицинский институт
2 shared publications - Artyom Mikhailovich Lutsenko
Department of Traumatology and Orthopaedics Peoples’ Friendship University of Russia Named After Patrice Lumumba Moscow Russia
1 shared publication - Av Vozzhaev
Peoples’ Friendship University of Russia named after Patrice Lumumba
1 shared publication - Irina I. Shkrebniova
Peoples’ Friendship University of Russia named after Patrice Lumumba
1 shared publication - Konstantin A. Miroshnikov
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str. 16/10, 117997 Moscow, Russia
1 shared publication - Olga Yu. Timoshina
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 14 November 2020
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 65 (5) , 259-266
A review of the regulatory framework for personalized bacteriophages registration
The increasing trend in antimicrobial resistance of pathogenic bacteria dictates the need for alternative solutions. Bacteriophages are bacterial viruses that kill their hosts during the lifecycle. The high specificity of phages makes the production of personalized cocktails the best option. Registration of drugs with variable composition lies beyond the current legal policies. In the present review, we studied the regulatory framework of the top 10 world economies from the point of personalized bacteriophages registration. We underlined procedures that countries can learn from each other.
- 14 November 2020
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 65 (5) , 259-266
Open AccessA review of the regulatory framework for personalized bacteriophages registration
The increasing trend in antimicrobial resistance of pathogenic bacteria dictates the need for alternative solutions. Bacteriophages are bacterial viruses that kill their hosts during the lifecycle. The high specificity of phages makes the production of personalized cocktails the best option. Registration of drugs with variable composition lies beyond the current legal policies. In the present review, we studied the regulatory framework of the top 10 world economies from the point of personalized bacteriophages registration. We underlined procedures that countries can learn from each other.
- 12 November 2020
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (5)
Lipid-lowering therapy in outpatients of different ages with coronary artery disease
Aim. To conduct a pharmacoepidemiologic analysis of lipid-lowering therapy (LLT) in outpatients of different ages with coronary artery disease (CAD). Material and methods . A total of 805 medical records of outpatients with CAD were analyzed in this pharmacoepidemiologic, cross-sectional study conducted at primary care facility of Moscow. The total sample of patients was divided into 3 age groups: group 1 — Conclusion. The study demonstrated no significant influence of patient age on LLT prescription rates, LDL-C control, and prevalence of irrational drug combinations in outpatients with CAD. Rates of dual LLT, structure and intensity of statin therapies differed depending on age groups.
- 12 November 2020
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (5)
Lipid-lowering therapy in outpatients of different ages with coronary artery disease
Aim. To conduct a pharmacoepidemiologic analysis of lipid-lowering therapy (LLT) in outpatients of different ages with coronary artery disease (CAD). Material and methods . A total of 805 medical records of outpatients with CAD were analyzed in this pharmacoepidemiologic, cross-sectional study conducted at primary care facility of Moscow. The total sample of patients was divided into 3 age groups: group 1 — Conclusion. The study demonstrated no significant influence of patient age on LLT prescription rates, LDL-C control, and prevalence of irrational drug combinations in outpatients with CAD. Rates of dual LLT, structure and intensity of statin therapies differed depending on age groups.